Clinical Trial Results TV
March 29, 2014: Dr. A. Michael Lincoff and Dr. C. Michael Gibson discuss: Evaluation of the Dual PPAR-α/γ Agonist Aleglitazar
Dr. A. Michael Lincoff and Dr. C. Michael Gibson discuss: Evaluation of the Dual
PPAR-α/γ Agonist Aleglitazar to Reduce Cardiovascular Events in Patients
with Acute Coronary Syndrome and Type 2 Diabetes Mellitus: the AleCardio Trial.

TBD

[ Download video ]


Video Statistics
0 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 0 total votes.

These statistics are updated nightly. The last update ran on
08-20-2017 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted